Skip to main content
FSCDR's 17th Annual SCD Research and Educational Symposium & 46th Nat'l SCD Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Stream
Live Stream
Back
Video

Curative Options in Sickle Cell Disease Plenary Session

Saturday, June 17, 2023
3:30 PM – 5:45 PM East Coast USA Time
Location: Grand Salons A-E
CE: 2

Live Stream

    Chair(s)

  • Courtney Fitzhugh, MD

    Investigator
    National Heart, Lung, and Blood Institute, National Institutes of Health
    Bethesda, Maryland, United States

Disclosure(s):
Courtney Fitzhugh, MD: No financial relationships to disclose

Learning Objectives:

  • Describe curative therapy options available for sickle cell disease including haploidentical transplant, gene therapy, and gene editing.
  • Describe risk factors for and strategies to evaluate leukemia development following curative therapies for sickle cell disease.
  • Describe what is known about long-term health effects of allogeneic transplant for sickle cell disease.

Presentations:

  • 3:30 PM – 3:45 PM East Coast USA Time
    Haploidentical HCT in SCD

    Speaker: Adetola Kassim, M.B.B.S, MS, FACP – Vanderbilt University Medical Center

  • 3:45 PM – 4:00 PM East Coast USA Time
    Lovotibeglogene autotemcel (lovo-cel) Gene Therapy for Sickle Cell Disease

    Speaker: Jen Leiding, MD (she/her/hers) – bluebird bio, Inc.

  • 4:00 PM – 4:15 PM East Coast USA Time
    Vertex Approach in Hemoglobinopathies

    Speaker: Aric Parnes, MD (he/him/his) – Vertex Phamaceuticals

  • 4:15 PM – 4:30 PM East Coast USA Time
    Editas and the Ruby Study

    Speaker: Olubunmi Afonja, MD, MBA (she/her/hers) – Editas Medicine

  • 4:30 PM – 4:45 PM East Coast USA Time
    Q&A Panel

    Panelist: Adetola Kassim, M.B.B.S, MS, FACP – Vanderbilt University Medical Center

    Panelist: Jen Leiding, MD (she/her/hers) – bluebird bio, Inc.

    Panelist: Aric Parnes, MD (he/him/his) – Vertex Phamaceuticals

    Panelist: Olubunmi Afonja, MD, MBA (she/her/hers) – Editas Medicine

  • 4:45 PM – 5:00 PM East Coast USA Time
    Leukemia Following Curative Therapies for Sickle Cell Disease

    Speaker: Courtney Fitzhugh, MD – National Heart, Lung, and Blood Institute, National Institutes of Health

  • 5:00 PM – 5:15 PM East Coast USA Time
    Clonal Hematopoieis

    Speaker: Coleman Lindsley, MD,PhD – Dana-Farber Cancer Institute

  • 5:15 PM – 5:30 PM East Coast USA Time
    Survivorship in Sickle Cell Disease

    Speaker: Elizabeth Stenger, MD – Emory University/Aflac Cancer & Blood Disorders Center

  • 5:30 PM – 5:45 PM East Coast USA Time
    Q&A Panel

    Panelist: Courtney Fitzhugh, MD – National Heart, Lung, and Blood Institute, National Institutes of Health

    Panelist: Coleman Lindsley, MD,PhD – Dana-Farber Cancer Institute

    Panelist: Elizabeth Stenger, MD – Emory University/Aflac Cancer & Blood Disorders Center